Report

Global Interventional Oncology Market Size study, By Product (Ablation, Particle Embolization, Support Devices), and Regional Forecasts 2022-2028

  • Publish Date: Sep,2022
  • Report ID: QI037
  • Page : 200
  • Report Type : PDF (Email)
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Global Interventional Oncology Market, by Region, 2020-2028 (USD Million)
1.2.2. Global Interventional Oncology Market, by Product, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Interventional Oncology Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Interventional Oncology Market Dynamics
3.1. Interventional Oncology Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growing penetration of Cancer worldwide.
3.1.1.2. Increasing demand for minimally invasive treatment procedures.
3.1.1.3. Recent collaboration activities from leading market players.
3.1.2. Market Challenges
3.1.2.1. Inadequate distribution of funds for the research purpose
3.1.2.2. Dearth of skilled professionals.
3.1.3. Market Opportunities
3.1.3.1. Growing number of R&D activities towards new cancer therapeutics.
3.1.3.2. Rising healthcare infrastructure in emerging economies.
Chapter 4. Global Interventional Oncology Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Interventional Oncology Market, by Product
6.1. Market Snapshot
6.2. Global Interventional Oncology Market by Product, Performance - Potential Analysis
6.3. Global Interventional Oncology Market Estimates & Forecasts by Product 2018-2028 (USD Million)
6.4. Interventional Oncology Market, Sub Segment Analysis
6.4.1. Ablation
6.4.2. Particle Embolization
6.4.3. Support Devices
Chapter 7. Global Interventional Oncology Market, Regional Analysis
7.1. Interventional Oncology Market, Regional Market Snapshot
7.2. North America Interventional Oncology Market
7.2.1. U.S. Interventional Oncology Market
7.2.1.1. Product estimates & forecasts, 2018-2028
7.2.2. Canada Interventional Oncology Market
7.3. Europe Interventional Oncology Market Snapshot
7.3.1. U.K. Interventional Oncology Market
7.3.2. Germany Interventional Oncology Market
7.3.3. France Interventional Oncology Market
7.3.4. Spain Interventional Oncology Market
7.3.5. Italy Interventional Oncology Market
7.3.6. Rest of Europe Interventional Oncology Market
7.4. Asia-Pacific Interventional Oncology Market Snapshot
7.4.1. China Interventional Oncology Market
7.4.2. India Interventional Oncology Market
7.4.3. Japan Interventional Oncology Market
7.4.4. Australia Interventional Oncology Market
7.4.5. South Korea Interventional Oncology Market
7.4.6. Rest of Asia Pacific Interventional Oncology Market
7.5. Latin America Interventional Oncology Market Snapshot
7.5.1. Brazil Interventional Oncology Market
7.5.2. Mexico Interventional Oncology Market
7.6. Rest of The World Interventional Oncology Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Alpinion Medical Systems Co. Ltd.
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. AngioDynamics
8.2.3. Boston Scientific Corporation
8.2.4. Hologic, Inc.
8.2.5. Medtronic Plc.
8.2.6. Merit Medical
8.2.7. Profound Medical
8.2.8. Siemens Healthineers
8.2.9. Teleflex Incorporated
8.2.10. Terumo Corporation
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption